Corrigendum to “ESPEN guideline: Clinical nutrition in inflammatory bowel disease” (Clinical Nutrition (2017) 36(2) (321–347), (S0261561416313681), (10.1016/j.clnu.2016.12.027))

The recommendations 14A, 32A, 33A, and 33B, which recommend “VSL#3 ® ”, refer only to the product used in the cited literature and equivalent products independent from the present product labelings. This product is now known by the generic name “De Simone Formulation”. The authors would like to apologise for any inconvenience caused